In vivo Evidence for Brain Region-Specific Molecular Interactions Between Cannabinoid and Orexin Receptors
Open Access
- 21 December 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 15, 790546
Abstract
The endocannabinoid and orexin neuromodulatory systems serve key roles in many of the same biological functions such as sleep, appetite, pain processing, and emotional behaviors related to reward. The type 1 cannabinoid receptor (CB1R) and both subtypes of the orexin receptor, orexin receptor type 1 (OX1R) and orexin receptor type 2 (OX2R) are not only expressed in the same brain regions modulating these functions, but physically interact as heterodimers in recombinant and neuronal cell cultures. In the current study, male and female C57BL/6 mice were co-treated with the cannabinoid receptor agonist CP55,940 and either the OX2R antagonist TCS-OX2-29 or the dual orexin receptor antagonist (DORA) TCS-1102. Mice were then evaluated for catalepsy, body temperature, thermal anti-nociception, and locomotion, after which their brains were collected for receptor colocalization analysis. Combined treatment with the DORA TCS-1102 and CP55,940 potentiated catalepsy more than CP55,940 alone, but this effect was not observed for changes in body temperature, nociception, locomotion, or via selective OX2R antagonism. Co-treatment with CP55,940 and TCS-1102 also led to increased CB1R-OX1R colocalization in the ventral striatum. This was not seen following co-treatment with TCS-OX2-29, nor in CB1R-OX2R colocalization. The magnitude of effects following co-treatment with CP55,940 and either the DORA or OX2R-selective antagonist was greater in males than females. These data show that CB1R-OX1R colocalization in the ventral striatum underlies cataleptic additivity between CP55,940 and the DORA TCS-1102. Moreover, cannabinoid-orexin receptor interactions are sex-specific with regards to brain region and functionality. Physical or molecular interactions between these two systems may provide valuable insight into drug-drug interactions between cannabinoid and orexin drugs for the treatment of insomnia, pain, and other disorders.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada
- College of Pharmacy and Nutrition, University of Saskatchewan
This publication has 59 references indexed in Scilit:
- The Dual Orexin Receptor Antagonist Almorexant Induces Sleep and Decreases Orexin-Induced Locomotion by Blocking Orexin 2 ReceptorsSLEEP, 2012
- The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependentlyInternational Journal of Neuropsychopharmacology, 2012
- Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin AJournal of Biological Chemistry, 2011
- Differential Roles of Orexin Receptor-1 and -2 in the Regulation of Non-REM and REM SleepJournal of Neuroscience, 2011
- Effects of endocannabinoid system modulation on cognitive and emotional behaviorFrontiers in Behavioral Neuroscience, 2011
- Sniffing out the contributions of the olfactory tubercle to the sense of smell: Hedonics, sensory integration, and more?Neuroscience & Biobehavioral Reviews, 2011
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- Enhanced Orexin Receptor-2 Signaling Prevents Diet-Induced Obesity and Improves Leptin SensitivityCell Metabolism, 2009
- Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and FunctionJournal of Biological Chemistry, 2006
- Cannabinoid receptors in rat brain areas: Sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacementLife Sciences, 1994